Company news

Pulse Biosciences, Inc news in 2025

Pulse Biosciences, Inc's news releases, calls and decks from 2025, newest first.

View company

Pulse Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference

December 28, 2025

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

December 18, 2025

Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation

December 17, 2025

Pulse Biosciences, Inc. Announces Initiation of Research Collaboration for the Treatment of Benign and Malignant Thyroid Tumors with nPulse™ Technology

December 8, 2025

Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences

November 5, 2025

Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results

November 4, 2025

Pulse Biosciences Announces First Enrollment in the NANOCLAMP AF Study

October 23, 2025

Pulse Biosciences Schedules Third Quarter 2025 Business Updates and Financial Results Conference Call for November 5, 2025

October 21, 2025

Pulse Biosciences Announces Presentation of Late-Breaking Data From the nPulse™ Cardiac Surgical System First-in-Human Feasibility Study at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting

October 9, 2025

Pulse Biosciences Announces Clinical Data Highlighting its nPulse™ Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting

October 6, 2025

Pulse Biosciences’ nPulse™ Technology to be Featured at the American Thyroid Association 2025 Annual Meeting

September 9, 2025

Pulse Biosciences Announces FDA IDE Approval to Initiate its nsPFA Cardiac Surgery System Study for the Treatment of Atrial Fibrillation

September 7, 2025

Pulse Biosciences Announces First Successful Procedures in PRECISE Benign Thyroid Nodule (BTN) Study

September 1, 2025

Pulse Biosciences Announces Publication of First-In-Human Data for Treatment of Benign Thyroid Nodules in the Journal Thyroid

August 25, 2025

Pulse Biosciences Reports Business Updates and Second Quarter 2025 Financial Results

August 11, 2025

Pulse Biosciences To Present at the 45th Canaccord Genuity Annual Growth Conference

July 31, 2025

Pulse Biosciences Schedules Second Quarter 2025 Business Updates and Financial Results Conference Call for August 12, 2025

July 28, 2025

Pulse Biosciences Reports Business Updates and First Quarter 2025 Financial Results

May 7, 2025

Pulse Biosciences To Present at the BofA Securities 2025 Health Care Conference

May 5, 2025

Pulse Biosciences’ Nanosecond PFA Technology to be Featured at The American Association for Thoracic Surgery 2025 Annual Meeting

April 30, 2025

Pulse Biosciences Schedules First Quarter 2025 Financial Results Conference Call for May 8, 2025

April 23, 2025

Pulse Biosciences’ Nanosecond PFA Technology to be Featured at The Heart Rhythm Society 2025 Annual Meeting

April 22, 2025

Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2024 Financial Results

March 26, 2025

Pulse Biosciences To Present at the 24th Annual Needham Virtual Health Care Conference

March 25, 2025

Pulse Biosciences Schedules Fourth Quarter & Full Year 2024 Financial Results Conference Call for March 27, 2025

March 6, 2025

Pulse Biosciences To Present at the TD Cowen 45th Annual Health Care Conference

February 19, 2025

Pulse Biosciences, Inc. Appoints Jon Skinner as Chief Financial Officer

February 3, 2025

Pulse Biosciences’ Nanosecond PFA Technology to Be Featured in Presentations at North American Society for Interventional Thyroidology Annual Meeting

January 29, 2025

Pulse Biosciences Announces Late-Breaking Data from its Nanosecond PFA 360° Cardiac Catheter System First-In-Human Feasibility Study Presented at the AF Symposium

January 20, 2025

Pulse Biosciences’ Nanosecond PFA Technology to be Featured in Multiple Presentations at the AF Symposium

January 12, 2025

Pulse Biosciences, Inc. Appoints Paul LaViolette as Chief Executive Officer

January 9, 2025

Pulse Biosciences To Present at the 43rd Annual J.P. Morgan Healthcare Conference

January 2, 2025

Calls in 2025

Decks in 2025